Antineoplastic/ bcma directed car-t cell immunotherapy. QTY: 1, breyanzi, 50-110M car POS t-cell CTN US. Lisocabtagene maraleucel approved for a veteran patient.
Ended Awarded Last action
- Contract number
- 36C24925F0120
- Awardee
-
Bristol-Myers Squibb Company UEI UFGKB2B71N12
- Awarding agency
-
Veterans Integrated Service Network 9
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $335,043
Award facts
- Contract value 100% obligated
- $335,042.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Lawrenceville, Lawrence Township, NJ 08648, USA
Award details come from SAM.gov/FPDS.
About this award
This federal contract award is for the delivery of BREYANZI, a chimeric antigen receptor (CAR) T cell immunotherapy product, to the Department of Veterans Affairs (VA) for the treatment of a veteran patient. The contract was awarded to Bristol-Myers Squibb Company, a large pharmaceutical manufacturer, and has a ceiling value of $335,042.65. The contract is a firm fixed price delivery order under Bristol-Myers Squibb's existing Federal Supply Schedule contract (ID: 36F79724D0101) with the VA, which covers a broad range of drugs, pharmaceuticals, and hematology-related products. This contract does not have a set-aside designation. The work will be primarily performed at Bristol-Myers Squibb's facility in Lawrenceville, New Jersey. The contract supports the VA's mission of providing advanced medical care, including specialized oncology and immunotherapy treatments, to eligible veterans.
Quick answers
Who was awarded contract 36C24925F0120?
36C24925F0120 was awarded to Bristol-Myers Squibb Company by Veterans Integrated Service Network 9 (Veterans Health Administration) on February 24, 2025.
How much is contract 36C24925F0120 worth?
The government has obligated $335,043 on 36C24925F0120.
Is contract 36C24925F0120 an order under another contract?
Yes. 36C24925F0120 is a delivery order under 36F79724D0101, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24925F0120 competed?
The extent of competition for 36C24925F0120 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award